B. Hartmann

发表

Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.

R. Greil, R. Kofler, S. Geley, 1997, Cancer research.

Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer.

T. Winder, M. Knauer, E. Wenzl, 2009, Oncology reports.

Irradiation induces G2/M cell cycle arrest and apoptosis in p53-deficient lymphoblastic leukemia cells without affecting Bcl-2 and Bax expression

R. Kofler, S. Geley, B. Hartmann, 1998, Cell Death and Differentiation.

Increased lactate production follows loss of mitochondrial membrane potential during apoptosis of human leukaemia cells

R. Kofler, R. Margreiter, G. Konwalinka, 2001, British journal of haematology.

Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents—A Prospective Cohort Study of the AGMT Study-Group

L. Pleyer, R. Greil, S. Machherndl-Spandl, 2022, Cancers.

Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl‐2, but not by CrmA

R. Kofler, S. Geley, B. Hartmann, 1997, FEBS letters.

The interleukin 1β‐converting enzyme inhibitor CrmA prevents Apo1/Fas‐ but not glucocorticoid‐induced poly(ADP‐ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells

R. Greil, R. Kofler, S. Geley, 1997 .

Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line.

R. Kofler, M. Fiegl, S. Geley, 1995, Cancer research.

The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells.

R. Greil, R. Kofler, S. Geley, 1997, FEBS letters.

Screening in Psycho-oncology---Need for Psycho-oncological and Psycho-social Care of Oncological Patients: A Pilot Survey Using the Hornheider Questionnaire

B. Hartmann, C. Saely, D. Zanolin, 2017 .

Screening in der Psychoonkologie

B. Hartmann, C. Saely, D. Zanolin, 2016, ProCare.

Screening in der Psychoonkologie

B. Hartmann, C. Saely, D. Zanolin, 2016, HeilberufeScience.

Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24).

R. Greil, M. Gnant, P. Dubsky, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Serological SARS‐CoV‐2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID‐19 vaccine in haematological and oncological patients

H. Ulmer, T. Winder, P. Fraunberger, 2021, British journal of haematology.

Genes mediating glucocorticoid effects and mechanisms of their regulation.

R. Kofler, M. Fiegl, S. Geley, 1996, Reviews of physiology, biochemistry and pharmacology.

c-Myc does not prevent glucocorticoid-induced apoptosis of human leukemic lymphoblasts

D. Bernhard, R. Kofler, S. Geley, 1999, Oncogene.

Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts

D. Bernhard, R. Kofler, A. Csordás, 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Bcl-2 interferes with the execution phase, but not upstream events, in glucocorticoid-induced leukemia apoptosis

R. Kofler, S. Geley, B. Auer, 1999, Oncogene.

A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients

T. Winder, B. Hartmann, H. Drexel, 2012, BMC Cancer.

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

G. Superti-Furga, U. Jaeger, B. Snijder, 2021, Cancer discovery.

Different types of KRas mutations are conversely associated with overall survival in patients with colorectal cancer

T. Winder, M. Knauer, E. Wenzl, 2022 .

HIV-triggered lymphoma

B. Hartmann, M. Atzl, 2019, memo - Magazine of European Medical Oncology.

Pomalidomide (POM) and Low-Dose Dexamethasone (LoDEX) in Relapsed/Refractory Multiple Myeloma (RRMM): Analysis of Real World Data from an Ongoing, National, Multi-Center, Non-Interventional Study

R. Greil, H. Gisslinger, H. Greinix, 2018, Blood.

Sequence-specific transcription factors during glucocorticoid-induced apoptosis in acute lymphoblastic leukemia cells.

R. Kofler, S. Geley, B. Hartmann, 1999, Wiener klinische Wochenschrift.

Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID‐19 vaccine in haemato‐oncological patients with no antibody response

H. Ulmer, T. Winder, P. Fraunberger, 2021, British journal of haematology.

Evaluation of the JAK2 V617F mutational status in coronary patients.

T. Winder, K. Geiger, B. Hartmann, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer—Results from the AGMT GASTRIC-5 Registry

R. Greil, C. Schmitt, P. Regitnig, 2020, Journal of clinical medicine.

Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.

R. Kofler, S. Geley, B. Hartmann, 1996, Cancer research.

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6)

R. Greil, C. Schmitt, H. Ulmer, 2016, Therapeutic advances in medical oncology.

Interaction between dexamethasone and butyrate in apoptosis induction: non-additive in thymocytes and synergistic in a T cell-derived leukemia cell line

D. Bernhard, R. Kofler, A. Csordás, 1999, Cell Death and Differentiation.

Glucocorticoid‐receptor‐gene defects and resistance to glucocorticoid‐induced apoptosis in human leukemic cell lines

R. Kofler, B. Hartmann, G. Böck, 1996, International journal of cancer.

The Cell Cycle Inhibitor p16INK4A Sensitizes Lymphoblastic Leukemia Cells to Apoptosis by Physiologic Glucocorticoid Levels*

R. Kofler, S. Geley, P. Obexer, 2001, The Journal of Biological Chemistry.

The cell cycle inhibitor p16(INK4A) sensitizes lymphoblastic leukemia cells to apoptosis by physiologic glucocorticoid levels.

R. Kofler, S. Geley, P. Obexer, 2001, The Journal of biological chemistry.

p53-induced apoptosis in the human T-ALL cell line CCRF-CEM

David Bernhard, D. Bernhard, R. Kofler, 1997, Oncogene.

Peripheral Blood Complete Remission Provides Added Value to the Classical Definition of Morphologic Complete Remission - a Prospective Cohort Study of 1441 Patients with MDS, CMML and AML Treated within the Austrian Azacitidine Registry

L. Pleyer, R. Greil, C. Schmitt, 2021, Blood.

Cox Proportional Hazards Deep Neural Network Identifies Peripheral Blood Complete Remission (PB-CR) to be at Least Equivalent to Morphologic CR in Predicting Outcomes of Patients Treated with Azacitidine - a Prospective Cohort Study By the AGMT

L. Pleyer, R. Greil, J. Hasenauer, 2022, Blood.